Systemic administration of anti-tumor necrosis factor alpha (anti-TNF alpha) leads to an anti-inflammatory and joint protective effect in pathologies such as rheumatoid arthritis, psoriasis, and Crohn's disease. The aim of this study was to assess adherence to therapy, persistence in treatment (no switches or interruptions), and consumption of care resources (drugs, outpatient services, hospitalizations).
Adherence and resource use among patients treated with biologic drugs : findings from BEETLE study / L. Degli Esposti, D. Sangiorgi, V. Perrone, S. Radice, E. Clementi, F. Perone, S. Buda. - In: CLINICOECONOMICS AND OUTCOMES RESEARCH. - ISSN 1178-6981. - 6:(2014), pp. 401-407. [10.2147/CEOR.S66338]
Adherence and resource use among patients treated with biologic drugs : findings from BEETLE study
V. Perrone;S. Radice;E. Clementi;
2014
Abstract
Systemic administration of anti-tumor necrosis factor alpha (anti-TNF alpha) leads to an anti-inflammatory and joint protective effect in pathologies such as rheumatoid arthritis, psoriasis, and Crohn's disease. The aim of this study was to assess adherence to therapy, persistence in treatment (no switches or interruptions), and consumption of care resources (drugs, outpatient services, hospitalizations).File | Dimensione | Formato | |
---|---|---|---|
ceor-6-401.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
322.8 kB
Formato
Adobe PDF
|
322.8 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.